Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS

11.75 Down 0.24(2.00%) May 17, 4:00PM EDT|After Hours : 11.75 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 730   21,947   9,357   10,569  
Cost of Revenue -   -   -   -  
Gross Profit 730   21,947   9,357   10,569  
Operating Expenses
Research Development10,313  9,097  9,860  8,818  
Selling General and Administrative3,392  4,268  3,459  3,131  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (12,975) 8,582   (3,962) (1,380)
Income from Continuing Operations
Total Other Income/Expenses Net900  908  884  879  
Earnings Before Interest And Taxes(12,075)9,490  (3,078)(501)
Interest Expense -   -   -   -  
Income Before Tax(12,075)9,490  (3,078)(501)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,075)9,490  (3,078)(501)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,075) 9,490   (3,078) (501)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,075) 9,490   (3,078) (501)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.